Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Home > Cartherics News > Biotech Daily: Cartherics, ToolGen …. Gene-Edit Stem Cells for Cancer Immunotherapies

Karen Loudon 2019-01-23T23:36:03+00:00 January 23rd, 2019|

The Pipeline

June 7, 2019

Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been...

General In the media PDF document

May 8, 2019

MEDIA RELEASE 8 May 2019 Parties use science to set themselves apart .... The major parties have laid out their science...

Conferences General

May 3, 2019

http://www.eradicatecancer2020.org